Assenagon Asset Management S.A. Purchases Shares of 181,565 Maximus, Inc. $MMS

Assenagon Asset Management S.A. purchased a new position in Maximus, Inc. (NYSE:MMS) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 181,565 shares of the health services provider’s stock, valued at approximately $15,673,000. Assenagon Asset Management S.A. owned approximately 0.33% of Maximus as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Arizona State Retirement System grew its stake in Maximus by 0.9% in the third quarter. Arizona State Retirement System now owns 16,674 shares of the health services provider’s stock worth $1,524,000 after purchasing an additional 156 shares in the last quarter. GAMMA Investing LLC raised its position in Maximus by 13.9% during the 3rd quarter. GAMMA Investing LLC now owns 1,337 shares of the health services provider’s stock valued at $122,000 after purchasing an additional 163 shares in the last quarter. Trust Point Inc. raised its position in Maximus by 3.7% during the 3rd quarter. Trust Point Inc. now owns 5,286 shares of the health services provider’s stock valued at $483,000 after purchasing an additional 191 shares in the last quarter. Richardson Financial Services Inc. lifted its holdings in shares of Maximus by 123.1% in the 3rd quarter. Richardson Financial Services Inc. now owns 348 shares of the health services provider’s stock worth $32,000 after buying an additional 192 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Maximus by 0.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock worth $2,351,000 after buying an additional 221 shares during the period. Institutional investors own 97.21% of the company’s stock.

Insider Buying and Selling

In other Maximus news, Director Jan Madsen sold 742 shares of Maximus stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $72.25, for a total value of $53,609.50. Following the transaction, the director directly owned 20,795 shares of the company’s stock, valued at approximately $1,502,438.75. The trade was a 3.45% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO David Mutryn purchased 1,000 shares of Maximus stock in a transaction dated Monday, February 9th. The shares were acquired at an average cost of $75.62 per share, for a total transaction of $75,620.00. Following the completion of the transaction, the chief financial officer owned 40,037 shares of the company’s stock, valued at approximately $3,027,597.94. This represents a 2.56% increase in their position. The disclosure for this purchase is available in the SEC filing. 1.80% of the stock is currently owned by company insiders.

Maximus Trading Down 2.6%

Shares of NYSE:MMS opened at $66.03 on Friday. The company has a market capitalization of $3.60 billion, a PE ratio of 10.05 and a beta of 0.59. The company has a current ratio of 2.34, a quick ratio of 2.34 and a debt-to-equity ratio of 0.88. Maximus, Inc. has a 12-month low of $64.68 and a 12-month high of $100.00. The business’s fifty day simple moving average is $79.89 and its 200-day simple moving average is $84.49.

Maximus (NYSE:MMS) last issued its quarterly earnings data on Thursday, February 5th. The health services provider reported $1.85 earnings per share for the quarter, topping analysts’ consensus estimates of $1.84 by $0.01. The firm had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.37 billion. Maximus had a return on equity of 25.30% and a net margin of 6.92%.The firm’s quarterly revenue was down 4.1% on a year-over-year basis. During the same period in the prior year, the business posted $1.61 EPS. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. As a group, equities research analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 2nd. Investors of record on Friday, February 13th were paid a dividend of $0.33 per share. This is a boost from Maximus’s previous quarterly dividend of $0.30. The ex-dividend date was Friday, February 13th. This represents a $1.32 annualized dividend and a dividend yield of 2.0%. Maximus’s dividend payout ratio (DPR) is presently 20.09%.

Analyst Ratings Changes

MMS has been the topic of several research reports. Zacks Research upgraded Maximus from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, December 30th. Wall Street Zen lowered shares of Maximus from a “buy” rating to a “hold” rating in a research note on Monday, February 23rd. Finally, Weiss Ratings cut shares of Maximus from a “buy (b)” rating to a “hold (c+)” rating in a report on Tuesday, February 24th. One analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Buy”.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.